Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 9 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-08-30 Kaufmann Hitto SVP, Chief Scientific Officer Grant or award · Stock Option (right to buy) +300,000 300,000
2019-07-31 Said Maya R. Director Grant or award · Stock Option (right to buy) +30,000 30,000
2019-07-25 Richman Michael Director Grant or award · Stock Option (right to buy) +3,789 $2.89 $11K 3,789
2019-04-25 Richman Michael Director Grant or award · Stock Option (right to buy) +5,640 $1.94 $11K 5,640
2019-02-26 Matis Louis Chief Development Officer Grant or award · Stock Option (Right to Buy) +96,500 96,500
2019-02-26 Reine Allan Chief Financial Officer Grant or award · Stock Options (Right to Buy) +162,500 162,500
2019-02-26 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Options (Right to Buy) +380,000 380,000
2019-01-30 BVF PARTNERS L P/IL 10% owner Other disposition −2,573,000 978,200
2019-01-30 BVF PARTNERS L P/IL 10% owner Other disposition −2,143,000 772,324
2019-01-30 BVF PARTNERS L P/IL 10% owner Other disposition −284,000 141,346
2019-01-30 BVF PARTNERS L P/IL 10% owner Other acquisition · Series B Convertible Preferred Stock, $0.001 par value +2,573 2,573
2019-01-30 BVF PARTNERS L P/IL 10% owner Other acquisition · Series B Convertible Preferred Stock, $0.001 par value +2,143 2,143
2019-01-30 BVF PARTNERS L P/IL 10% owner Other acquisition · Series B Convertible Preferred Stock, $0.001 par value +284 284
2019-01-25 Sherman Matthew L Director Grant or award · Stock Option (right to buy) +20,000 20,000
2019-01-25 Richman Michael Director Grant or award · Stock Option (right to buy) +6,096 $1.79 $11K 6,096
2019-01-25 Richman Michael Director Grant or award · Stock Option (right to buy) +20,000 20,000
2019-01-25 Prelack Steven Director Grant or award · Stock Option (right to buy) +20,000 20,000
2019-01-25 KIRITSY CHRISTOPHER P Director Grant or award · Stock Option (right to buy) +20,000 20,000
2019-01-25 Kiener Peter A Director Grant or award · Stock Option (right to buy) +20,000 20,000
2019-01-25 BIZZARI JEAN-PIERRE Director Grant or award · Stock Option (right to buy) +20,000 20,000

Page 14 of 21 · 412 trades